Carl St. Bernard

Lumendi’s #dilumen platform saves time and cost when performing complex polypectomy. If you perform #ESD and/or suture in the #colon, you need this! #endoscopy #colonoscopy #gastroenterology

14

A great reminder during #PADAwareness month. #PAD, a blockage in any of the arteries in the legs, can be serious. Learn more about risk factors, prevention and treatment strategies

38

OEM vs. 3rd party endoscope repair? This #whitepaper reveals how two ambulatory surgery centers made their choice. Real-world scenarios, practical insights. bit.ly/oem-service24 #OlympusService #OlympusPost

6

🚨 Fighting Undilatable Coronary Lesions with Precision and Safety 🚨 The article, “OPN NCTM TWIN-Wall fighting against undilatable lesions,” highlights a groundbreaking solution for interventional cardiologists facing one of the most significant challenges in PCI—undilatable coronary lesions. In this study, the OPN NC® Super High-Pressure PTCA Balloon demonstrates its ability to successfully treat lesions that traditional balloons cannot. Operating at pressures up to 40 atm, OPN NC® balloons achieve uniform expansion, making them the ideal solution for calcified and complex lesions that demand maximum precision. The study revealed impressive outcomes: OPN NC® was able to dilate highly resistant lesions with remarkable safety and efficiency, significantly reducing the rate of complications. This further reinforces OPN NC®’s position as the go-to tool for treating complex coronary conditions, ensuring better patient outcomes and improved procedural success in even the most difficult cases. While we push the boundaries of what’s possible in PCI, radiation safety should never be overlooked. Procedures like these often involve extended use of fluoroscopy, exposing healthcare workers to significant levels of scatter radiation. That’s why RADPAD® Radiation Protection Shields are crucial. RADPAD® shields offer vital protection against ionizing radiation, ensuring that interventional teams can focus on delivering the best care while staying safe. Combining the precision of the OPN NC® Super High-Pressure Balloon with the safety of RADPAD® shields, interventional cardiologists can confidently tackle the most complex cases with optimal results and minimal risk. Read the full article here: https://lnkd.in/gpKviFDb #InterventionalCardiology #PCI #HealthcareInnovation #OPNNC #RADPAD #RadiationProtection #UndilatableLesions #Cardiology

32

We’ve all been waiting for Stryker to dive into the M&A deep end. Does the Inari Medical deal qualify? I say yes. The #peripheralvascular space is BOOMING! 💣 And Stryker's WIN BIG attitude will be a jetpack strapped on the Inari sales team. News of the deal brought me back to my great conversation with Andy Pierce, group president of the Stryker business that made the deal. I interviewed him at DeviceTalks West. Of course, I asked a lot about Stryker M&A. Just prior to DeviceTalks West, Pierce’s Neurovascular and MedSurg business had just bought five companies over the previous four months, but everyone was still waiting for the big one. Here's what I learned from Pierce. (This comes up around the 30 minute mark but you're nuts if you don’t listen to the entire interview. A few pull outs - direct quotes are in quotes 🚀 Stryker typically will take YEARS building a relationship with a company it acquires -  "Each business is responsible for maintaining their roster of potential deals that they can do and working closely with management in those companies over time." 🚀 Stryker buys performance - "We're looking for milestones. We very rarely buy companies that are pre-market. Usually we want to see some commercial traction in those businesses. So we look for milestones in that. And then we're more than willing to pay a little bit more to have a de-risked technology or company that we acquire. 🚀 Stryker isn't afraid to bid - "A lot of our deals, you can see are public and we, I think, are known as a disciplined but fair buyer in the marketplace." 🚀 Stryker's leaders take time to know M&A targets. "I'll personally get involved, my counterpart, Spencer Stiles, will get involved with many of these deals and building relationships with management over time. We think that being able to look across the table and when it actually comes down to having a negotiation, that a relationship matters." 🚀 Relationships are critical - "We do a lot of work to make sure that we have the right partner, they have the right partner, and that we have the trust. It doesn't mean we don't get into fierce negotiations. Of course, we almost always do. But we typically have a very high comfort level with one another before that happens." 🚀 Internal R&D is critical - Stryker commits 7% of sales to internal R&D - but the company asks engineers to look past `Not Invented Here' syndrome - "We [bring] along our R&D teams as well as to why we may actually pursue something outside the company and why that might be a better use of time or investment to go ahead and do that. But if you look at our growth trajectory ... and the percentage of revenue that comes from newer technologies that we bring to market that are Stryker inventions or that we've acquired. The growth that we drive year-over-year is about 50-50 between companies that have been brought into the company and their technologies and our own organic innovations that we bring to market."

542

15 Comments

AI has the potential to help dental professionals gain a better understanding of patient experience data. This technology can make an incredible impact, as it's critical for providers to gain insights into what their patients need and want in their oral care. It's important to understand generational differences in patient experience and acknowledge that each individual experiences the dental care system in a different way, from how they get information and how they provide feedback to their care expectations. Have you noticed differences between your older and younger patients? If so, what have you done to accommodate their needs and preferences? #AI #PatientExperience #Data #SICAT #surgicalguides #dentalimplant #3dprinting

2

You'll spend hours finding the perfect zirconia specs for your clients. But 3x markup on identical prosthetic components? That just slides right through procurement. (We see you nodding, dental lab owners)!! Here's what your competitors already figured out: Those FDA-cleared components you're ordering? They're literally identical to ours. Same precision engineering. Same compatibility. Same #quality your clients trust. The only difference? You're paying extra for someone else's marketing budget. Smart lab owners are done playing that game. Ready to put your materials expertise to work on your bottom line? Click to see what you should actually be paying>>> https://lnkd.in/dGvq3zRV Bhi Implants Ltd #DentalLab #SmartProcurement #LabOwners

8

1 Comment

Hearing loss and tinnitus are the leading service-related injuries affecting U.S. Veterans. And they're not alone: Over 740 million adults worldwide feel the effects of tinnitus. Our #StarkeyEdgeAI hearing aids have a tinnitus management solution that can help provide much-needed customizable and adaptable relief for those with this common condition. #ProtectYourHearing #Tinnitus #VeteransDay

25

If you're a refractive surgeon, your biggest competitor is not your neighbor down the street. It's indifference and lack of awareness. I receive google news alerts on a variety of topics and this one in Forbes caught me by surprise yesterday morning. How is it possible that 𝟮𝟱 𝘆𝗲𝗮𝗿𝘀 𝗹𝗮𝘁𝗲𝗿, we are still addressing the basic questions about LASIK? This is an unfortunate example of how we as an industry (surgeons, manufacturers and other stakeholders) have done a terrible job of educating the public on the benefits of vision correction procedures. Together, we can do better. Full article: https://lnkd.in/drm32jhm #ophthalpreneurs #privatepractice #leadership #ophthalmology #ophthalmologist #refractivesurgery #lensreplacement #personalizedvision

43

15 Comments

MedTech, a $500 billion industry will more than double as TechMed becomes the new market driver. Alan Cohen, head of the prolific DCVC investment group that is fueling the next generation of medical devices has identified a new segment of the medical device industry, “TechMed”. “Whereas MedTech players are primarily product companies that monetize device sales, TechMed companies are funda­men­tally software- and platform-centric.” “The economics and business-model impli­ca­tions of the TechMed movement more closely mirror the dynamics we see from dominant tech platforms and ecosystems.” Immersive medicine, the use of media as medicine, sits firmly in the TechMed space and will drive considerable job growth for those capable of wielding media to impact change to human health and behavior while generating an amazingly potent data stream. Read all of Alan’s thesis here: https://lnkd.in/gx5BMab2 See him present next at LSI’s awesome medical conference on September 19th (Day 3) at #LSIEurope24 in Sintra, Portugal.

150

31 Comments

Video 3 or 3. In this final video installment with MedTech Voice (MTV), Jay and I discuss the excitement surrounding the injection of technological and procedural innovation into the orthopaedic surgical arena. Johnson & Johnson MedTech | Orthopaedics's investment and delivery of innovations to the market over the last 3-4 years has been nothing short of historic. American Association of Hip and Knee Surgeons (AAHKS), Johnson & Johnson MedTech #committedpartner #mycompany #jnj #VELYS #KINCISE #ATTUNE #ENHANCE #EMPHASYS #ACTIS #CUPTIMIZE #ASC

66

1 Comment

Make your case… I contend that the push by certain sectors of industry to consolidate/limit vendors (i.e. competition) is done at the expense of surgeons and patients. ➤ An open market: 🔹 Drives Innovation 🔹 Promotes Cost Reduction 🔹 Increases Potential Solutions ——————————————————————— Access to the open market maximizes options for surgeons and patients. No single company regardless of size and scope has the best product offering for every surgeon and every situation. Disagree? Tell me why in the comments. #orthopedics #medicaldevicesales #surgeons

791

128 Comments

Lumicell was granted FDA approval for the first NDA & PMA in the last 10 years this past April. With 84% accuracy, this phenomenal combination product identifies residual cancer tissue in real time that could have been missed during surgery. Historically, 1 in 8 women developed breast cancer and due to the challenges of eliminating the entire tumor, up to 36% of women need a second surgery. This incredible technology can help create greater patient outcomes and increase healthcare efficiency by reducing the need for second surgeries. Most of us know or have known someone who has been affected by cancer and to understand that a loved one has gotten through surgery successfully without any residual cancer cells would provide an incredible peace of mind. https://lnkd.in/ekaNs8ny #innovation #breastcancer #oncology #medtech #FDAapproval #cuttingedgetechnology

7

🌟 Missed the OPN NC® Satellite Symposium at TCT 2024? We’ve got you covered! 🌟 Discover how the OPN NC® Super High-Pressure PTCA Balloon is transforming the management of complex PCI cases. During this compelling panel discussion, leading experts in interventional cardiology shared clinical insights, innovative techniques, and real-world outcomes demonstrating OPN NC's unmatched performance in tackling challenges like In-Stent Restenosis (ISR), calcified lesions, and lesion preparation. Key topics covered: ✅ Clinical challenges in complex PCI and ISR ✅ Innovative applications with OPN NC: Clinical evidence and real-world results ✅ Uncompromised safety and effectiveness vs. other therapies in PCI ✅ Case studies: Delivering successful outcomes in the most complex lesions 🎥 Watch the full discussion now and learn how OPN NC can elevate your practice: https://lnkd.in/g4EqYv3a Join the conversation on advancing patient care with OPN NC®! Emmanouil (Manos) Brilakis Nachiket Patel, MD, FACC, FACP, FSCAI Stéphane Rinfret, MD,SM Natalia Pinilla Darshan Doshi Florim Cuculi #TCT2024 #ComplexPCI #OPNNC #InterventionalCardiology #LesionPreparation #ISR #HealthcareInnovation

2

Imagine a world where the tiniest patients receive the safest iv care possible. Thanks to groundbreaking optical sensor technology, that world is closer than you think. So, why should you chat with our ivWatch, LLC team? 1. We offer enhanced neonatal care. Preterm infants are vulnerable to vascular cannulation risks. However, with the new ivWatch®, early infiltration detection is revolutionising neonatal care. 2. We offer consistent and impressive results. A pilot study showed a 93.3% sensitivity in detecting infiltrations, outperforming traditional methods. This means: ·       earlier detection ·       increased safety ·       improved outcomes 3. We will support you with a step towards safer healthcare. Continuous monitoring is the future. It's efficient and strategic and aligns with our commitment to excellence in patient care. The future of neonatal IV care is on the horizon, driven by the innovative optical sensor technology of ivWatch. This groundbreaking advancement is set to transform the landscape of neonatal healthcare by providing enhanced safety and early detection of infiltrations, particularly for our most vulnerable patients. With a proven % sensitivity rate of 93.3% in pilot studies, ivWatch outperforms traditional methods, ensuring earlier detection, increased safety, and improved outcomes. Embracing continuous monitoring aligns with the highest standards of patient care and represents a significant step towards safer healthcare practices. Engage with our #ivWatch team to explore how we can collectively advance neonatal care and safeguard the health of our tiniest patients. #HelenStephens #medtech #innovation #neonatalcare #patientsafety

17

This 2023 report from the American Urological Association (AUA) rings alarm bells. Soaring demand for urological intervention confronting shrinking urologist capacity to treat patients.  Into this stressed environment, Avvio Medical’s Microsphere Cavitation System will make its entrance with market clearance expected in 2025. It offers to fundamentally redraw the patient journey, unload our strained infrastructure, and address the foundational supply and demand equation that AUA is bringing to our attention.   https://lnkd.in/gt5KVMMi   Avvio will do this:  1. by bringing ordinary urologists (not just Board certified endourologists) into the practice of stone management in their home towns, close to the patients. 2. Eliminating general anesthesia, fluoroscopy, diagnostic imaging ultrasound and recovery room staffing and scheduling needs, also under critical pressure, lowering costs and dramatically improving workflows and lowering total cost of care. 3. Enabling a site of service expansion to bring simple "every town" cysto suites ASC's and OBL's into stone disease treatment. We foresee thousands of dedicated "stone clinics" being enabled by our technology. The doctors we are in constant communication with share this gigantic vision! 4. Lowering the capital cost of equipment to allow small and less well funded clinics to acquire all the equipment it needs to start its own stone clinic in days without massive cash outlays. The Avvio System hardware will be available at ~10% of the cost of a modern US shockwave lithotripsy set up and ~25% of the cost of its laser counterpart. This scalability will allow stone clinics to proliferate rapidly across the US and all the large economies of the world. #AUA #urology #urologist #ASC #kidneystonedisease #lithotripsy #laserlithotripsy #shockwavelithotripsy #cavitation #microbubble #avviomedical www.avviomed.com

46

1 Comment

20 years of the same actions. Not surprisingly, 20 years of the same results. Take refractive surgery, for example. Commoditization, shifting share from one company or one practice to the next, market growth flat or just barely creeping along. To be such an amazing and life-changing procedure, this is a sad situation. Private ophthalmology is stuck in a loop, with the gap between what public and private deliver growing wider. Let’s face it—what works in public healthcare doesn’t work here. Private practice must be different. I’m here push boundaries, connect new dots, and redefine what’s possible. I unite private ophthalmology stakeholders to grow the market and help more patients benefit from advanced solutions. I empower doctors to find their voice, build trust through authentic branding, and streamline patient journeys for better engagement and education. As the founder of Ophthalpreneurs™, I’ve built a community where private ophthalmology stakeholders collaborate, solve business challenges, and master the skills medical school didn’t teach. This isn’t about small tweaks—it’s about transformation. If you’re ready to leave “business as usual” behind and step into a future where private ophthalmology leads rather than sits on the sidelines, let’s talk. #ophthalpreneurs #privatepractice #ophthalmology #leadership #innovation #refractivesurgery #lensreplacement #cataract #glaucoma #dryeye

43

🌟 exChange Circle Webinar – Supercharge your Business - Adding Specialties for DSOs 🌟 Last Thursday, I had the privilege of moderating the Women in DSO exChange Circle webinar series on behalf of Straumann Group DSO Global, featuring three exceptional panelists from #DSOs. Together, we delved into the captivating topic of the impact of adding specialties for DSOs on profitability. While patient experience remains paramount for DSOs, achieving sustainable success also hinges on profitability. 🔑 Key Takeaways: CULTURE, LEADERSHIP, EDUCATION: Establishing a robust workplace culture and fostering leadership skills for doctors are crucial for scaling success. Investing in education and promoting a culture of continuous learning are pivotal drivers. Leadership among doctors plays a key role in ensuring a consistent commitment to delivering high standards of care. Moreover, educating patients about the importance of oral healthcare and implementing robust education programs for various roles within the practices further enhance the quality of care. 🚀 Key Challenges Explored: Jumoke Adedoyin, DDS, MICOI, MAAIP AFAAID: Navigating patient priorities amidst economic fluctuations poses challenges, particularly as dental care may not be a top priority for patients allocating disposable income. Standardizing quality of care across practices by streamlined processes is essential to ensure uniformity and high standards. Harnessing technology and making data-driven decisions are crucial for optimizing operations and ensuring efficiency. Niklas Virta: Educating patients on the value of services beyond the public system is vital. Striking a balance between streamlining processes and nurturing an entrepreneurial spirit is key. Culture serves as a cornerstone for success, and integrating specialists into the company is essential when adding specialties. Having these specialists fully embracing and embodying the company culture is essential to preserve a strong company culture that directly impacts profitability. Dr. Dev Patel BDS PG Dip: Getting specialty services to grow can be challenging for various reasons. In the UK, many patients associate dentistry with low-cost services due to the accessibility of NHS dentistry, leading to a lack of understanding regarding the value of specialty dentistry. It's essential to inform patients on the relevance of oral healthcare to overcome this perception. Educating dentists on effectively communicating the necessity and value of specialty services to patients is crucial. This engaging discussion illuminated the dynamic landscape of DSOs and provided invaluable insights for navigating challenges while fostering growth. Thank you Dr. Aman Kaur , Brenda McKinnon, and the Women In DSO® Team, as well as our esteemed panelists Jumoke Adedoyin, DDS, MICOI, MAAIP AFAAID, Dr. Dev Patel BDS PG Dip, Niklas Virta, and all participants for enriching this dialogue! #DSO #Profitability #GrowthStrategies #Leadership #Education

69

3 Comments